Cited by 5,850Lipoproteins and Cardiovascular HealthInflammatory Biomarkers in Disease PrognosisAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

Open access

Ridker, Paul M., Hennekens, Charles H., Buring, Julie E., Rifai, Nader·2000·New England Journal of Medicine

DOI 10.1056/nejm200003233421202

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Since inflammation is believed to have a role in the pathogenesis of cardiovascular events, measurement of markers of inflammation has been proposed as a method to improve the prediction of the risk of these events. METHODS: We conducted a prospective, nested case-control study among 28,263 apparently healthy postmenopausal women over a mean follow-up period of three years to assess the risk of cardiovascular events associated with base-line levels of markers of inflammation. The markers included high-sensitivity C-reactive protein (hs-CRP), serum amyloid A, interleukin-6, and soluble intercellular adhesion molecule type 1 (sICAM-1). We also studied homocysteine and a variety of lipid and lipoprotein measurements. Cardiovascular events were defined as death from coronary heart disease, nonfatal myocardial infarction or stroke, or the need for coronary-revascularization procedures. RESULTS: Of the 12 markers measured, hs-CRP was the strongest univariate predictor of the risk of cardiovascular events; the relative risk of events for women in the highest as compared with the lowest quartile for this marker was 4.4 (95 percent confidence interval, 2.2 to 8.9). Other markers significantly associated with the risk of cardiovascular events were serum amyloid A (relative risk for the highest as compared with the lowest quartile, 3.0), sICAM-1 (2.6), interleukin-6 (2.2), homocysteine (2.0), total cholesterol (2.4), LDL cholesterol (2.4), apolipoprotein B-100 (3.4), HDL cholesterol (0.3), and the ratio of total cholesterol to HDL cholesterol (3.4). Prediction models that incorporated markers of inflammation in addition to lipids were significantly better at predicting risk than models based on lipid levels alone (P<0.001). The levels of hs-CRP and serum amyloid A were significant predictors of risk even in the subgroup of women with LDL cholesterol levels below 130 mg per deciliter (3.4 mmol per liter), the target for primary prevention established by the National Cholesterol Education Program. In multivariate analyses, the only plasma markers that independently predicted risk were hs-CRP (relative risk for the highest as compared with the lowest quartile, 1.5; 95 percent confidence interval, 1.1 to 2.1) and the ratio of total cholesterol to HDL cholesterol (relative risk, 1.4; 95 percent confidence interval, 1.1 to 1.9). CONCLUSIONS: The addition of the measurement of C-reactive protein to screening based on lipid levels may provide an improved method of identifying persons at risk for cardiovascular events.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm200003233421202

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Self-citation
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,354
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men
Köenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,952
Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
Self-citation
Production of C-reactive protein and risk of coronary events in stable and unstable angina
Haverkate, E., Thompson, S. G., Pyke, S., Gallimore, J. R., & Mark B Pepys Group (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,511

Show all 30 references

Research works printed but not linked: 1

Buring JE, 1992, J Myocard Ischemia, 4, 27

Sorted by citations

Items 601–700 of 1,069

β2-Microglobulin as a Biomarker in Peripheral Arterial Disease
Wilson, A., Kimura, E., Harada, R. K., Nair, N., Narasimhan, B., Meng, X.-Y., Zhang, F., Beck, K. R., Olin, J. W., Fung, E. T., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.683722 · Cited by 189
PCSK9 and inflammation: a review of experimental and clinical evidence
Momtazi-Borojeni, A. A., Sabouri-Rad, S., Gotto, A. M., Pirro, M., Banach, M., Awan, Z., Barreto, G. E., & Sahebkar, A. (2019) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvz022 · Cited by 188
Airflow Limitation in Smokers Is Associated with Subclinical Atherosclerosis
Iwamoto, H., Yokoyama, A., Kitahara, Y., Ishikawa, N., Haruta, Y., Yamane, K., Hattori, N., Hara, H., & Kohno, N. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200804-560oc · Cited by 188
Detection of Helicobacter pylori in Human Carotid Atherosclerotic Plaques
Ameriso, S. F., Fridman, E. A., Leiguarda, R. C., & Sevlever, G. E. (2001) · Stroke · doi:10.1161/01.str.32.2.385 · Cited by 188
C-Reactive Protein Predicts Further Ischemic Events in First-Ever Transient Ischemic Attack or Stroke Patients With Intracranial Large-Artery Occlusive Disease
Arenillas, J. F., Álvarez‐Sabín, J., Molina, C. A., Chacón, P. M., Montaner, J., Rovira, À., Ibarra, B., & Quintana, M. (2003) · Stroke · doi:10.1161/01.str.0000089920.93927.a7 · Cited by 188
Adipose tissue and metabolic syndrome: too much, too little or neither
Grundy, S. M. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12519 · Cited by 187
Decreased Levels of Plasma Vitamin C and Increased Concentrations of Inflammatory and Oxidative Stress Markers After Stroke
Sánchez‐Moreno, C., Dashe, J. F., Scott, T. M., Thaler, D. E., Folstein, M. F., & Martin-Marco, A. (2003) · Stroke · doi:10.1161/01.str.0000105391.62306.2e · Cited by 187
A pilot study of a Mediterranean-type diet intervention in female patients with rheumatoid arthritis living in areas of social deprivation in Glasgow
McKellar, G., Morrison, E., McEntegart, A., Hampson, R., Tierney, A. M., Mackle, G., Scoular, J., Scott, J. A., & Capell, H. A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.065151 · Cited by 187
Relationships of Circulating Carotenoid Concentrations with Several Markers of Inflammation, Oxidative Stress, and Endothelial Dysfunction: The Coronary Artery Risk Development in Young Adults (CARDIA)/Young Adult Longitudinal Trends in Antioxidants (YALTA) Study
Hozawa, A., Jacobs, D. R., Steffes, M. W., Gross, M. D., Steffen, L. M., & Lee, D. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.074930 · Cited by 186
Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk
Ridker, P. M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.06.082 · Cited by 186
Self-citation
Anti-GPIIb/IIIa Drugs: Current Strategies and Future Directions
Coller, B. S. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616241 · Cited by 186
Pleiotropic effects of HMG-CoA reductase inhibitors
Werner, N., Nickenig, G., & Laufs, U. (2002) · Basic Research in Cardiology · doi:10.1007/s003950200000 · Cited by 186
Measures of Insulin Resistance Add Incremental Value to the Clinical Diagnosis of Metabolic Syndrome in Association With Coronary Atherosclerosis
Reilly, M. P., Wolfe, M. L., Rhodes, T., Girman, C., Mehta, N., & Rader, D. J. (2004) · Circulation · doi:10.1161/01.cir.0000138740.84883.9c · Cited by 185
C-reactive protein: a nontraditional serum marker of cardiovascular risk
de Ferranti, S. D., & Rifai, N. (2007) · Cardiovascular Pathology · doi:10.1016/j.carpath.2006.04.006 · Cited by 185
Self-citation
Association of chronic kidney disease with clinical outcomes after coronary revascularization: The arterial revascularization therapies study (ARTS)
Ix, J. H., Mercado, N. F., Shlipak, M. G., Lemos, P. A., Boersma, E. H., Lindeboom, W. K., O’Neill, W. W., Wijns, W. C., & Serruys, P. W. J. C. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.10.010 · Cited by 185
The Role of Oxidative Stress–Altered Lipoprotein Structure and Function and Microinflammation on Cardiovascular Risk in Patients with Minor Renal Dysfunction
Kaysen, G. A., & Eiserich, J. P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000111744.00916.e6 · Cited by 185
Religious Participation, Interleukin-6, and Mortality in Older Adults.
Lutgendorf, S. K., Russell, D., Ullrich, P., Harris, T. B., & Wallace, R. (2004) · Health Psychology · doi:10.1037/0278-6133.23.5.465 · Cited by 184
Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: Insights from the National Health and Nutrition Examination Survey-III
Shah, N. N., Parikh, V. K., Patel, N., Patel, N., Badheka, A., Deshmukh, A. J., Rathod, A. D., & Lafferty, J. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.12.019 · Cited by 184
Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate
Deutschman, D. H., Carstens, J. S., Klepper, R. L., Smith, W. S., Page, M. T., Young, T. R., Gleason, L. A., Nakajima, N., & Sabbadini, R. A. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00118-2 · Cited by 184
Effect of Different Classes of Antihypertensive Drugs on Endothelial Function and Inflammation
Silva, I. V. G., de Figueiredo, R. C., & Rios, D. R. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143458 · Cited by 184
Inflammatory cytokines, socioeconomic status, and acute stress responsivity
Steptoe, A., Owen, N., Kunz-Ebrecht, S., & Mohamed‐Ali, V. (2002) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(02)00030-2 · Cited by 183
Trans fatty acids: Effects on cardiometabolic health and implications for policy
Micha, R., & Mozaffarian, D. (2008) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.09.008 · Cited by 182
YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance
Rathcke, C. N., Johansen, J. S., & Vestergaard, H. (2006) · Inflammation Research · doi:10.1007/s00011-005-0010-8 · Cited by 182
Interleukin-6 Covaries Inversely With Cognitive Performance Among Middle-Aged Community Volunteers
Marsland, A. L., Petersen, K. L., Sathanoori, R., Muldoon, M. F., Neumann, S. A., Ryan, C. M., Flory, J. D., & Manuck, S. B. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000238451.22174.92 · Cited by 182
Hepatic Steatosis, Obesity, and the Metabolic Syndrome Are Independently and Additively Associated With Increased Systemic Inflammation
Ndumele, C. E., Nasir, K., Conceição, R., Carvalho, J. A. M., Blumenthal, R. S., & Santos, R. D. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.228262 · Cited by 182
Plasma Adiponectin, Insulin Sensitivity, and Subclinical Inflammation in Women With Prior Gestational Diabetes Mellitus
Winzer, C., Wagner, O. F., Festa, A., Schneider, B., Roden, M., Bancher‐Todesca, D., Pacini, G., Funahashi, T., & Kautzky‐Willer, A. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1721 · Cited by 181
Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men
Laufs, U., Waßmann, S., Hilgers, S., Ribaudo, N., Böhm, M., & Nickenig, G. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02095-1 · Cited by 181
Effects of Weight Loss and Long-Term Weight Maintenance With Diets Varying in Protein and Glycemic Index on Cardiovascular Risk Factors: The Diet, Obesity, and Genes (DiOGenes) Study: A Randomized, Controlled Trial
Gögebakan, Ö., Kohl, A., Osterhoff, M. A., van Baak, M. A., Jebb, S. A., Papadaki, A., Martinez, J. A., Handjieva-Darlenska, T., Hlavaty, P., Weickert, M. O., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.033274 · Cited by 180
Chemokines and Cardiovascular Risk
Aukrust, P., Halvorsen, B. L., Yndestad, A., Ueland, T., Øie, E., Otterdal, K., Gullestad, L. L., & Damås, J. K. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.161240 · Cited by 180
C-reactive protein and interleukin-6 in vascular disease
Rattazzi, M., Puato, M., Faggin, E., Bertipaglia, B., Zambon, A., & Pauletto, P. (2003) · Journal of Hypertension · doi:10.1097/00004872-200310000-00002 · Cited by 180
Depression in Patients with Coronary Heart Disease
Carney, R. M., & Freedland, K. E. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.010 · Cited by 179
Income, Education, and Inflammation: Differential Associations in a National Probability Sample (The MIDUS Study)
Friedman, E. M., & Herd, P. (2010) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181cfe4c2 · Cited by 179
High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events
Jia, C., Anderson, J. L. C., Gruppen, E. G., Yu, L., Bakker, S. J. L., Dullaart, R. P. F., & Tietge, U. J. F. (2021) · Circulation · doi:10.1161/circulationaha.120.050808 · Cited by 179
Extreme sleep durations and increased C-reactive protein: effects of sex and ethnoracial group
Grandner, M. A., Buxton, O. M., Jackson, N., Sands-Lincoln, M., Pandey, A., & Jean-Louis, G. (2013) · SLEEP · doi:10.5665/sleep.2646 · Cited by 178
Effect of physical activity on serum C-reactive protein
Albert, M. A., Glynn, R. J., & Ridker, P. M. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.09.046 · Cited by 178
Self-citation
Serum amyloid A impairs the antiinflammatory properties of HDL
Han, C. Y., Tang, C., Guevara, M. E., Hao, W., Wietecha, T., Shao, B., Subramanian, S., Omer, M., Wang, S., O’Brien, K. D., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83475 · Cited by 178
Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease
Pasterkamp, G., den Ruijter, H. M., & Libby, P. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.166 · Cited by 178
Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease
Aday, A. W., & Ridker, P. M. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00016 · Cited by 178
Self-citation
Elevated serum levels of soluble adhesion molecules predict death in pre‐dialysis patients: association with malnutrition, inflammation, and cardiovascular disease
Stenvinkel, P., Lindholm, B., Heimbürger, M., & Heimbürger, O. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.10.1624 · Cited by 178
C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: The EPIC-Norfolk prospective population study 1993–2003
Boekholdt, S. M., Hack, C. E., Sandhu, M. S., Luben, R., Bingham, S. A., Wareham, N. J., Peters, R. J. G., Jukema, J. W., Day, N., Kastelein, J. J. P., et al. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.09.023 · Cited by 177
Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study
Park, Y., Choi, H. K., Kim, M.-Y., Lee, W. K., Song, J., Kim, D.-K., & Lee, S.-K. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01186-5 · Cited by 176
Asthma Predicts Cardiovascular Disease Events
Tattersall, M. C., Guo, M., Korcarz, C. E., Gepner, A. D., Kaufman, J. D., Liu, K., Barr, R. G., Donohue, K. M., McClelland, R. L., Delaney, J. A., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305452 · Cited by 176
Inflammation as a Therapeutic Target in Atherosclerosis
Nguyen, M. T., Fernando, S., Schwarz, N., Tan, J. T. M., Bursill, C. A., & Psaltis, P. J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081109 · Cited by 176
Dietary Inflammatory Index and Incidence of Cardiovascular Disease in the SUN Cohort
Ramallal, R., Toledo, E., Martínez‐González, M. Á., Hernández, A., García‐Arellano, A., Shivappa, N., Hébert, J. R., & Ruiz‐Canela, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135221 · Cited by 175
C-reactive protein: history and revival
Ablij, H. C., & Meinders, A. E. (2002) · European Journal of Internal Medicine · doi:10.1016/s0953-6205(02)00132-2 · Cited by 175
Systemic and Cardiovascular Effects of Airway Injury and Inflammation: Ultrafine Particle Exposure in Humans
Frampton, M. W. (2001) · Environmental Health Perspectives · doi:10.1289/ehp.01109s4529 · Cited by 175
The role of heat shock proteins in atherosclerosis
Wick, G., Jakic, B., Buszko, M., Wick, M. C., & Grundtman, C. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.91 · Cited by 174
A Yearlong Exercise Intervention Decreases CRP among Obese Postmenopausal Women
Campbell, P. T., Campbell, K. L., Wener, M. H., Wood, B. L., Potter, J. D., McTiernan, A., & Ulrich, C. M. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31819c7feb · Cited by 174
Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome
Santos, A. C., Lopes, C. M. M., Guimarães, J. T., & Barros, H. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803035 · Cited by 174
Inflammation and Glucose Intolerance
Wolf, M. S., Sauk, J. S., Shah, A., Smirnakis, K. V., Jimenez-Kimble, R., Ecker, J. L., & Thadhani, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.21 · Cited by 174
Relation of the −174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization
Burzotta, F., Iacoviello, L., Castelnuovo, A. F. D., Glieca, F., Luciani, N., Zamparelli, R., Schiavello, R., Donati, M. B., Maseri, A., Possati, G., et al. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02046-x · Cited by 174
Relation of High-Sensitivity C-Reactive Protein, Interleukin-6, Tumor Necrosis Factor-Alpha, and Fibrinogen to Abdominal Adipose Tissue, Blood Pressure, and Cholesterol and Triglyceride Levels in Healthy Postmenopausal Women
Piché, M., Lemieux, S., Weisnagel, S. J., Corneau, L., Nadeau, A., & Bergeron, J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.02.051 · Cited by 173
Association Between 5-Lipoxygenase Expression and Plaque Instability in Humans
Cipollone, F., Mezzetti, A., Fazia, M. L., Cuccurullo, C., Iezzi, A., Ucchino, S., Spigonardo, F., Bucci, M., Cuccurullo, F., Prescott, S. M., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000172632.96987.2d · Cited by 173
Insight into the nature of the CRP–coronary event association using Mendelian randomization
Casas, J. P., Shah, T., Cooper, J. A., Hawe, E., McMahon, A. D., Gaffney, D., Packard, C. J., O’Reilly, D. S. J., Juhan-Vague, I., Yudkin, J. S., et al. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl041 · Cited by 172
IL-6, TNF-α and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort
Haddy, N. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00287-9 · Cited by 172
Comparison of Interleukin-6 and C-Reactive Protein for the Risk of Developing Hypertension in Women
Sesso, H. D., Wang, L., Buring, J. E., Ridker, P. M., & Gaziano, J. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000252664.24294.ff · Cited by 172
Self-citation
Dietary carbohydrates, physical inactivity, obesity, and the ‘metabolic syndrome’ as predictors of coronary heart disease
Liu, S., & Manson, J. E. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200108000-00005 · Cited by 172
Dietary nitrite prevents hypercholesterolemic microvascular inflammation and reverses endothelial dysfunction
Stokes, K. Y., Dugas, T. R., Tang, Y., Garg, H., Guidry, E., & Bryan, N. S. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01291.2008 · Cited by 171
Endothelial Dysfunction and Inflammation: Immunity in Rheumatoid Arthritis
Yang, X., Chang, Y., & Wei, W. (2016) · Mediators of Inflammation · doi:10.1155/2016/6813016 · Cited by 171
Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts
Abbruzzese, T. A., Havens, J. M., Belkin, M., Donaldson, M. C., Whittemore, A. D., Liao, J. K., & Conte, M. S. (2004) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2003.12.027 · Cited by 171
Increased Cardiovascular Disease Risk Indices in HIV-Infected Women
Dolan, S. E., Hadigan, C. M., Killilea, K. M., Sullivan, M. P., Hemphill, L., Lees, R. S., Schoenfeld, D., & Grinspoon, S. K. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000159323.59250.83 · Cited by 171
C-Reactive Protein and High-Sensitivity C-Reactive Protein: An Update for Clinicians
Windgassen, E. B., Funtowicz, L., Lunsford, T. N., Harris, L. A., & Mulvagh, S. L. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.01.2252 · Cited by 170
Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women
Williams, M. J. A., Poulton, R., & Williams, S. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00233-2 · Cited by 170
Prevention of Inflammation-Induced Endothelial Dysfunction
Kharbanda, R. K., Walton, B., Allen, M. L., Klein, N. J., Hingorani, A. D., MacAllister, R. J., & Vallance, P. J. (2002) · Circulation · doi:10.1161/01.cir.0000017863.52347.6c · Cited by 170
Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD
Cooper, B. A., Penne, E. L., Bartlett, L. H., & Pollock, C. A. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.08.045 · Cited by 170
Effect of Volunteering on Risk Factors for Cardiovascular Disease in Adolescents: A Randomized Controlled Trial
Schreier, H. M. C., Schonert-Reichl, K. A., & Chen, E. (2013) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2013.1100 · Cited by 169
Atherosclerosis—An immune disease
Hansson, G. K. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.08.039 · Cited by 169
Admixture Mapping of an Allele Affecting Interleukin 6 Soluble Receptor and Interleukin 6 Levels
Reich, D., Patterson, N. J., Ramesh, V., Jager, P. L. D., McDonald, G. J., Tandon, A., Choy, E., Hu, D., Tamraz, B., Pawlikowska, L., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/513206 · Cited by 169
Kidney function and markers of inflammation in elderly persons without chronic kidney disease: The health, aging, and body composition study
Keller, C., Odden, M. C., Fried, L. F., Newman, A. B., Angleman, S. B., Green, C. A., Cummings, S. R., Harris, T. B., & Shlipak, M. G. (2006) · Kidney International · doi:10.1038/sj.ki.5002042 · Cited by 169
Associations of Dietary Long-Chain n-3 Polyunsaturated Fatty Acids and Fish With Biomarkers of Inflammation and Endothelial Activation (from the Multi-Ethnic Study of Atherosclerosis [MESA])
He, K., Liu, K., Daviglus, M. L., Jenny, N. S., Mayer‐Davis, E. J., Jiang, R., Steffen, L. M., Siscovick, D. S., Tsai, M. Y., & Herrington, D. M. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.01.016 · Cited by 169
Rationale, Design, and Methodology of the Women’s Genome Health Study: A Genome-Wide Association Study of More Than 25 000 Initially Healthy American Women
Ridker, P. M., Chasman, D. I., Zee, R. Y. L., Parker, A. N., Rose, L. M., Cook, N. R., Buring, J. E., & for the Women’s Genome Health Study Working Group (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.099366 · Cited by 169
Self-citation
Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial
Ridker, P. M., MacFadyen, J. G., Glynn, R. J., Bradwin, G., Hasan, A., & Rifai, N. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa160 · Cited by 169
Self-citation
Paraoxonase, a cardioprotective enzyme: continuing issues
Getz, G. S., & Reardon, C. A. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200406000-00005 · Cited by 169
Angiotensin II Induces Interleukin-6 in Humans Through a Mineralocorticoid Receptor–Dependent Mechanism
Luther, J. M., Gainer, J. V., Murphey, L. J., Yu, C., Vaughan, D. E., Morrow, J. D., & Brown, N. J. (2006) · Hypertension · doi:10.1161/01.hyp.0000248135.97380.76 · Cited by 169
Interleukin-6 Is Associated With Cognitive Function: The Northern Manhattan Study
Wright, C. B., Sacco, R. L., Rundek, T., Delman, J. B., Rabbani, L. E., & Elkind, M. S. V. (2006) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2005.08.009 · Cited by 168
Biomarkers of abdominal aortic aneurysm progression. Part 2: inflammation
Hellenthal, F. A. M. V. I., Buurman, W. A., Wodzig, W. K. W. H., & Schurink, G. W. H. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.102 · Cited by 168
Evaluation of the Effect of Neptune Krill Oil on Chronic Inflammation and Arthritic Symptoms
Deutsch, L. (2007) · Journal of the American College of Nutrition · doi:10.1080/07315724.2007.10719584 · Cited by 168
Diabetes and inflammation: Fundamental aspects and clinical implications
Garcia, C., Fève, B., Ferré, P., Halimi, S., Baïzri, H., Bordier, L., Guiu, G., Dupuy, O., Bauduceau, B., & Mayaudon, H. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.07.001 · Cited by 167
Endothelial dysfunction: A key to the pathophysiology and natural history of peripheral arterial disease?
Brevetti, G., Schiano, V., & Chiariello, M. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.11.002 · Cited by 167
Interleukin‐6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID‐TIMI 52 (Stabilization of Plaque Using Darapladib—Thrombolysis in Myocardial Infarction 52) Trial
Fanola, C. L., Morrow, D. A., Cannon, C. P., Jarolím, P., Lukas, M. A., Bode, C., Hochman, J. S., Goodrich, E. L., Braunwald, E., & O’Donoghue, M. L. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005637 · Cited by 167
Acute phase reactant serum amyloid A in inflammation and other diseases
Zhang, Y., Zhang, J., Sheng, H., Li, H., & Wang, R. (2019) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.01.002 · Cited by 167
Quantitative Proteome Analysis of Human Plasma following in Vivo Lipopolysaccharide Administration Using 16O/18O Labeling and the Accurate Mass and Time Tag Approach
Qian, W., Monroe, M. E., Liu, T., Jacobs, J., Anderson, G., Shen, Y., Moore, R., Anderson, D. J., Zhang, R., Calvano, S. E., et al. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500045-mcp200 · Cited by 167
Effect of Shiftwork on Systemic Markers of Inflammation
Puttonen, S., Viitasalo, K., & Härmä, M. (2011) · Chronobiology International · doi:10.3109/07420528.2011.580869 · Cited by 166
Dietary hyperglycemia, glycemic index and metabolic retinal diseases
Chiu, C., & Taylor, A. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.09.001 · Cited by 166
Inflammation and the Development of Atherosclerosis
Mizuno, Y., Jacob, R. F., & Mason, R. P. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.7591 · Cited by 166
Is Hypertension an Inflammatory Process?
Boos, C., & Lip, G. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776843313 · Cited by 165
Compromised LCAT Function Is Associated With Increased Atherosclerosis
Hovingh, G. K., Hutten, B. A., Holleboom, A. G., Petersen, W., Rol, P., Stalenhoef, A. F. H., Zwinderman, A. H., de Groot, E., Kastelein, J. J. P., & Kuivenhoven, J. A. (2005) · Circulation · doi:10.1161/circulationaha.105.540427 · Cited by 165
Endothelial Dysfunction and Low-Grade Inflammation Are Associated With Greater Arterial Stiffness Over a 6-Year Period
van Bussel, B. C. T., Schouten, F., Henry, R. M. A., Schalkwijk, C. G., de Boer, M. R., Ferreira, I., Smulders, Y. M., Twisk, J. W. R., & Stehouwer, C. D. A. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.174557 · Cited by 165
Diabetes and Cardiovascular Disease
Resnick, H. E., & Howard, B. V. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103904 · Cited by 165
Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal
Sites, C. K., Toth, M. J., Cushman, M., L’Hommedieu, G. D., Tchernof, A., Tracy, R. P., & Poehlman, É. T. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02934-x · Cited by 164
Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women
Giugliano, G., Nicoletti, G., Grella, E., Giugliano, F. M., Esposito, K., Scuderi, N., & D’Andrea, F. (2004) · British Journal of Plastic Surgery · doi:10.1016/j.bjps.2003.12.010 · Cited by 164
Carbamylated low-density lipoprotein induces endothelial dysfunction
Speer, T., Owala, F. O., Holy, E. W., Zewinger, S., Frenzel, F., Stähli, B. E., Razavi, M., Triem, S., Cvija, H., Rohrer, L., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu111 · Cited by 164
Activation and Coagulation Biomarkers Are Independent Predictors of the Development of Opportunistic Disease in Patients with HIV Infection
Rodger, A., Fox, Z. V., Lundgren, J. D., Kuller, L. H., Boesecke, C., Gey, D., Skoutelis, A., Goetz, M. B., Phillips, A. N., & the INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2009) · The Journal of Infectious Diseases · doi:10.1086/605447 · Cited by 164
A Novel Anti-Inflammatory Role of Omega-3 PUFAs in Prevention and Treatment of Atherosclerosis and Vascular Cognitive Impairment and Dementia
Simonetto, M., Infante, M., Sacco, R. L., Rundek, T., & Della‐Morte, D. (2019) · Nutrients · doi:10.3390/nu11102279 · Cited by 164
Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant ???atheroma???
Valantine, H. A. (2003) · Transplantation · doi:10.1097/01.tp.0000080981.90718.eb · Cited by 164
Endothelial Dysfunction and Low-Grade Inflammation Explain Much of the Excess Cardiovascular Mortality in Individuals With Type 2 Diabetes: The Hoorn Study
de Jager, J., Dekker, J. M., Kooy, A., Kostense, P. J., Nijpels, G., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000215951.36219.a4 · Cited by 163
Increase in Serum Amyloid A Evoked by Dietary Cholesterol Is Associated With Increased Atherosclerosis in Mice
Lewis, K. E., Kirk, E. A., McDonald, T. O., Wang, S., Wight, T. N., O’Brien, K. D., & Chait, A. (2004) · Circulation · doi:10.1161/01.cir.0000136819.93989.e1 · Cited by 163
The physiology of optimizing health with a focus on exercise as medicine
Pedersen, B. K. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114339 · Cited by 163
Baseline Repeated Measures from Controlled Human Exposure Studies: Associations between Ambient Air Pollution Exposure and the Systemic Inflammatory Biomarkers IL-6 and Fibrinogen
Thompson, A. M. S., Zanobetti, A., Silverman, F., Schwartz, J. D., Coull, B. A., Urch, B., Speck, M., Brook, J. R., Manno, M., & Gold, D. R. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0900550 · Cited by 163
The role of estrogen in cardiovascular disease
Baker, L., Meldrum, K. K., Wang, M., Sankula, R., Vanam, R. P., Raiesdana, A., Tsai, B. M., Hile, K. L., Brown, J. W., & Meldrum, D. R. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00215-4 · Cited by 163

Authors: Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N.
Affiliations: Brigham and Women's Hospital (US)
Boston Children's Hospital (US)
ORCID: Ridker, Paul M.
Hennekens, Charles H.
Buring, Julie E.
Rifai, Nader
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2000-03-23
Volume: 342
Issue: 12
Pages: 836-843
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm200003233421202
OpenAlex: W2058610272
Cited by: 5,850
References: 30
Citations by year: 2026: 97 · 2025: 120 · 2024: 113 · 2023: 125 · 2022: 148 · 2021: 143 · 2020: 165 · 2019: 140 · 2018: 167 · 2017: 131 · 2016: 169 · 2015: 199 · 2014: 223 · 2013: 234 · 2012: 258
FWCI: 286.27
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
University Libraries (University of Maryland) (submittedVersion)
Digital Repository at the University of Maryland (University of Maryland College Park)
Funders: National Institutes of Health (5r01hl043851-10)
National Heart, Lung, and Blood Institute (R01HL058755, HL43851, HL-58755)
National Cancer Institute (CA-47988, R01CA047988)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords: C-reactive protein, inflammatory markers, cardiovascular risk prediction, postmenopausal women, serum amyloid A, interleukin-6, sICAM-1, homocysteine, apolipoprotein B-100, LDL cholesterol, coronary artery disease, myocardial infarction, stroke, coronary revascularization, risk prediction model
MeSH terms: Serum Amyloid A Protein, Analysis of Variance, Apolipoproteins, C-Reactive Protein, Cardiovascular Diseases, Female, Homocysteine, Humans, Lipids, Middle Aged, Prospective Studies, Protein Precursors, Risk, Biomarkers, Interleukin-6, Case-Control Studies, Intercellular Adhesion Molecule-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks